Clinical Trial Update: Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update outlines Phase 2 and Phase 3 studies evaluating midodrine in patients with heart failure with reduced ejection fraction and hypotensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Midodrine (Midodrine)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Heart Failure With Reduced Ejection Fraction, Hypotension | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING